Home › NDC Lookup › RxCUI directory › RxCUI 1437285

24 HR topiramate 100 MG Extended Release Oral Capsule [Trokendi] — RxCUI 1437285

RxNorm drug concept · Semantic branded drug
RxCUI 1437285 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 20 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1437285
Official name24 HR topiramate 100 MG Extended Release Oral Capsule [Trokendi]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as24 HR Trokendi 100 MG Extended Release Oral Capsule; Trokendi XR 100 MG 24HR Extended Release Oral Capsule; Trokendi XR 100 MG 24 HR Extended Release Oral Capsule
FDA products mapped4
Package NDCs mapped20
Reported Medicaid activity (SDUD)13,873 prescriptions · 29 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Topiramate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
📖 Read our full Topiramate guide →

🕸️ Concept Web — How 24 HR topiramate 100 MG Extended Release Oral Ca... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR topiramate 100 MG Extended Release Oral Capsule [Trokendi] RxCUI 1437285

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Topiramate 38404
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Trokendi 1436240
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Topiramate Extended Release Oral Capsule 1436238
    • Topiramate Oral Product 1162749
    • Topiramate Pill 1162750
    • Topiramate Extended Release Oral Capsule [Trokendi] 1436242
    • Trokendi Oral Product 1436243
    • Trokendi Pill 1436244
    • Extended Release Oral Capsule 316943
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Topiramate 100 MG [Trokendi] SBDC · 1437284
  • Topiramate Extended Release Oral Capsule [Trokendi] SBDF · 1436242
  • Trokendi Oral Product SBDG · 1436243
  • Trokendi Pill SBDG · 1436244
  • Trokendi BN · 1436240

📦 FDA Products & Package NDCs

4 products · 20 package NDCs
20 package NDCs map to RxCUI 1437285 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
17772-0101-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-101-01) Trokendi XR Supernus Pharmaceuticals, Inc. 2013-08-16
17772-0101-07 7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-101-07) Trokendi XR Supernus Pharmaceuticals, Inc. 2020-06-23
17772-0101-10 5 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (17772-101-10) Trokendi XR Supernus Pharmaceuticals, Inc. 2013-08-16
17772-0101-12 7 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (17772-101-12) Trokendi XR Supernus Pharmaceuticals, Inc. 2013-08-16
17772-0101-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-101-30) Trokendi XR Supernus Pharmaceuticals, Inc. 2013-08-16
17772-0102-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-102-01) Trokendi XR Supernus Pharmaceuticals, Inc. 2013-08-16
17772-0102-07 7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-102-07) Trokendi XR Supernus Pharmaceuticals, Inc. 2020-06-23
17772-0102-10 5 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (17772-102-10) Trokendi XR Supernus Pharmaceuticals, Inc. 2013-08-16
17772-0102-12 7 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (17772-102-12) Trokendi XR Supernus Pharmaceuticals, Inc. 2013-08-16
17772-0102-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-102-30) Trokendi XR Supernus Pharmaceuticals, Inc. 2013-08-16
17772-0103-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-103-01) Trokendi XR Supernus Pharmaceuticals, Inc. 2013-08-16
17772-0103-07 7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-103-07) Trokendi XR Supernus Pharmaceuticals, Inc. 2020-06-23
17772-0103-10 5 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (17772-103-10) Trokendi XR Supernus Pharmaceuticals, Inc. 2013-08-16
17772-0103-12 7 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (17772-103-12) Trokendi XR Supernus Pharmaceuticals, Inc. 2013-08-16
17772-0103-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-103-30) Trokendi XR Supernus Pharmaceuticals, Inc. 2013-08-16
17772-0104-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-104-01) Trokendi XR Supernus Pharmaceuticals, Inc. 2013-08-16
17772-0104-07 7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-104-07) Trokendi XR Supernus Pharmaceuticals, Inc. 2020-06-23
17772-0104-10 5 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (17772-104-10) Trokendi XR Supernus Pharmaceuticals, Inc. 2013-08-16
17772-0104-12 7 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (17772-104-12) Trokendi XR Supernus Pharmaceuticals, Inc. 2013-08-16
17772-0104-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-104-30) Trokendi XR Supernus Pharmaceuticals, Inc. 2013-08-16
Observed labelers: Supernus Pharmaceuticals, Inc. (20) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.